By analogy, FTI treatment causes mitotic stress leading to cGAS-STING signaling, which might explain the dose-dependent FTI decrease in cell growth and promotion of SNS as observed in different cell types including cancer cells [79,80]. The gene discussed is STING1; the disease is cancer.